Clinical activity of anti -programmed death-1 (PD-1) agents in acral and mucosal melanoma.

被引：1
|
作者：
Munhoz, Rodrigo Ramella
Shoushtari, Alexander Noor
Kuk, Deborah
Ott, Patrick Alexander
Johnson, Douglas Buckner
Tsai, Katy K.
Rapisuwon, Suthee
Eroglu, Zeynep
Sullivan, Ryan J.
Luke, Jason John
Gangadhar, Tara C.
Salama, April K.
Clark, Varina
Burias, Clare
Puzanov, Igor
Atkins, Michael B.
Algazi, Alain Patrick
Ribas, Antoni
Wolchok, Jedd D.
Postow, Michael Andrew
机构：
[1] Hosp Sirio Libanes, Sao Paulo, Brazil
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
[5] UC San Francisco, San Francisco, CA USA
[6] Gerogetown Univ Hosp, Washington, DC USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[8] Massachusetts Gen Hosp, Boston, MA 02114 USA
[9] Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA
[10] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[11] Duke Univ, Durham, NC USA
[12] Mem Sloan Kettering Canc Ctr, Mt Vernon, NY USA
[13] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[14] Lombardi Comprehens Canc Ctr, Washington, DC USA
[15] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.9516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9516
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Correlation between metastatic site and response to anti-Programmed Death-1 (PD-1) agents in melanoma.
    Goldinger, Simone M.
    Tsai, Katy K.
    Tumeh, Paul
    Hamid, Omid
    Nosrati, Adi
    Loo, Kimberly
    Grimes, Barbara
    Algazi, Alain Patrick
    Levesque, Mitchell P.
    Dummer, Reinhard
    Daud, Adil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Anti-Programmed Cell Death-1 (PD-1) Monoclonal Antibodies in Treating Advanced Melanoma - A Clinical Update
    Van Anh Trinh
    Joseph, Jocelyn
    Hwu, Wen-Jen
    [J]. DISCOVERY MEDICINE, 2018, 25 (135) : 31 - 40
  • [3] Anti-Programmed Cell Death-1 (PD-1) Monoclonal Antibodies in Treating Advanced Melanoma
    Metcalfe, Whitney
    Anderson, Jaime
    Van Anh Trinh
    Hwu, Wen-Jen
    [J]. DISCOVERY MEDICINE, 2015, 19 (106) : 393 - 401
  • [4] The Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma
    Shoushtari, Alexander N.
    Munhoz, Rodrigo R.
    Kuk, Deborah
    Ott, Patrick A.
    Johnson, Douglas B.
    Tsai, Katy K.
    Rapisuwon, Suthee
    Eroglu, Zeynep
    Sullivan, Ryan J.
    Luke, Jason J.
    Gangadhar, Tara C.
    Salama, April K. S.
    Clark, Varina
    Burias, Clare
    Puzanov, Igor
    Atkins, Michael B.
    Algazi, Alain P.
    Ribas, Antoni
    Wolchok, Jedd D.
    Postow, Michael A.
    [J]. CANCER, 2016, 122 (21) : 3354 - 3362
  • [5] Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients
    Valentine Heidelberger
    François Goldwasser
    Nora Kramkimel
    Anne Jouinot
    Nathalie Franck
    Jennifer Arrondeau
    Sarah Guégan
    Audrey Mansuet-Lupo
    Jérôme Alexandre
    Diane Damotte
    Marie-Françoise Avril
    Nicolas Dupin
    Sélim Aractingi
    [J]. Investigational New Drugs, 2017, 35 : 842 - 847
  • [6] Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients
    Heidelberger, Valentine
    Goldwasser, Francois
    Kramkimel, Nora
    Jouinot, Anne
    Franck, Nathalie
    Arrondeau, Jennifer
    Guegan, Sarah
    Mansuet-Lupo, Audrey
    Alexandre, Jerome
    Damotte, Diane
    Avril, Marie-Francoise
    Dupin, Nicolas
    Aractingi, Selim
    [J]. INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 842 - 847
  • [7] Programmed death-1 (PD-1) Expression in Sezary Syndrome
    Wehkamp, U.
    Oschlies, I
    Brasch, J.
    Klapper, W.
    Weichenthal, M.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 (09): : 922 - 922
  • [8] Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.
    Nie, Run-Cong
    Yuan, Shu-Qiang
    Li, Yuanfang
    Chen, Yingbo
    Zhou, Zhiwei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Kao, Justin C.
    Brickshawana, Adipong
    Liewluck, Teerin
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (10)
  • [10] Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors
    Justin C. Kao
    Adipong Brickshawana
    Teerin Liewluck
    [J]. Current Neurology and Neuroscience Reports, 2018, 18
12345